ダイト(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4577/E24187 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2023/05/26 | 日証協 | 54,333株 | -28.25% | 6,800株 | -82.01% | 254,253株 | +113.22% | 137,087株 | +59.63% |
2023/05/19 | 日証協 | 75,722株 | +0.22% | 37,800株 | +57.94% | 119,244株 | +4.44% | 85,880株 | +59.92% |
2023/05/12 | 日証協 | 75,554株 | -41.07% | 23,933株 | +9999.99% | 114,175株 | -19.41% | 53,701株 | -4.18% |
2023/05/02 | 日証協 | 128,210株 | -1.08% | 87株 | -99.79% | 141,675株 | +0.07% | 56,043株 | +3429.16% |
2023/04/28 | 日証協 | 129,610株 | +4.32% | 41,331株 | +127.61% | 141,574株 | -8.83% | 1,588株 | -54.3% |
2023/04/21 | 日証協 | 124,248株 | -8.46% | 18,159株 | -59.89% | 155,291株 | -6.99% | 3,475株 | -89.87% |
2023/04/14 | 日証協 | 135,738株 | -5.22% | 45,278株 | -20.72% | 166,962株 | -1.17% | 34,300株 | -49.68% |
2023/04/07 | 日証協 | 143,216株 | -6.54% | 57,110株 | +21.99% | 168,939株 | -10.65% | 68,160株 | -13.63% |
2023/03/31 | 日証協 | 153,241株 | +1% | 46,816株 | +53.21% | 189,081株 | +24.78% | 78,914株 | +1692.69% |
2023/03/24 | 日証協 | 151,721株 | -2.82% | 30,557株 | -54.44% | 151,528株 | -1.11% | 4,402株 | -48.28% |
2023/03/17 | 日証協 | 156,130株 | +4.62% | 67,072株 | -24.49% | 153,228株 | -0.54% | 8,511株 | -74.49% |
2023/03/10 | 日証協 | 149,230株 | +45.73% | 88,822株 | +90.83% | 154,057株 | +17.56% | 33,367株 | +197.18% |
2023/03/03 | 日証協 | 102,401株 | +13.26% | 46,544株 | +99.14% | 131,049株 | +0.3% | 11,228株 | -24.64% |
2023/02/24 | 日証協 | 90,409株 | -0.96% | 23,372株 | +105.25% | 130,655株 | +1.25% | 14,899株 | +325.69% |
2023/02/17 | 日証協 | 91,285株 | -20.92% | 11,387株 | -70.97% | 129,042株 | -14.7% | 3,500株 | -72.14% |
2023/02/10 | 日証協 | 115,428株 | +33.16% | 39,224株 | +31.51% | 151,272株 | -0.15% | 12,564株 | -77.51% |
2023/02/03 | 日証協 | 86,683株 | -15.8% | 29,827株 | +264.86% | 151,493株 | -17.44% | 55,869株 | +122.33% |
2023/01/27 | 日証協 | 102,948株 | -13.43% | 8,175株 | -83.91% | 183,498株 | -11.77% | 25,129株 | -27.44% |
2023/01/20 | 日証協 | 118,918株 | +6.49% | 50,820株 | -2.31% | 207,985株 | -8.01% | 34,630株 | +32.37% |
※株式分割は考慮していませんのでご注意ください。
Page Top